Print this page    •   Back to Web version of article

U.S. News
Boehringer Ingelheim Launches Hepatitis C Web Portal for Patients, Health Care Providers

January 17, 2013

The pharmaceutical company Boehringer Ingelheim recently launched the website www.HepCRedefined.com to provide resources and tools for individuals infected with the hepatitis C virus (HCV). The company collaborated with HCV community advocates and healthcare providers to create the portal, which offers a range of interactive tools and information that can be shared through social media channels, placed on other websites, or viewed on various smart devices. Michael Ninburg, executive director of the Hepatitis Education Project, states that "HepCRedefined.com is designed to aggregate straightforward and accurate information in a single, virtual destination." CDC estimates the United States recorded 16,000 cases of acute HCV and 3.2 million individuals with chronic HCV infection in 2009.

Back to other news for January 2013

Excerpted from:
Gastroenterology & Endoscopy News
01.2013




This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/70323/boehringer-ingelheim-launches-hepatitis-c-web-port.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.